CAR-T therapy following autologous stem cell transplant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T therapy following autologous stem cell transplant, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors [Phase 2]